Atlas Trials

Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy

Clinical trial NCT05584267 · RECRUITING

Trial details

NCT number
NCT05584267
Sponsor
Hunan Province Tumor Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Non Small Cell Lung Cancer
Start date
2022-12-25
Primary completion
2025-11-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.